In the Capital Connectors series, exclusive interviews with six influential Chinese and global bankers reveal the opportunities and challenges for…
Read More »DeepSeek moment
Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…
Read More »Hong Kong’s market watchdog and stock exchange operator have set up a special communication channel and a new confidential filing…
Read More »

